What Researchers Did
This study reported on a single case of a woman who experienced blindness after receiving an autologous fat injection for cosmetic purposes.
What They Found
A 30-year-old woman developed immediate visual loss in her right eye after autologous fat injection into her glabellar area. Examinations revealed complete obstruction of her right ophthalmic artery, leading to blindness and widespread retinal damage. Despite treatments including urokinase, corticosteroids, and hyperbaric oxygen therapy, her vision did not improve.
What This Means for Canadian Patients
This case highlights a rare but severe risk of blindness associated with autologous fat injections, particularly in the glabellar region, for cosmetic procedures. Canadian patients considering such cosmetic treatments should be aware of potential vascular complications, including ophthalmic artery occlusion. It also suggests that even with immediate medical intervention, including HBOT, visual outcomes for this specific complication may be poor.
Canadian Relevance
The study is not Canadian and does not involve Canadian authors. It covers a complication related to cosmetic surgery, which is not a Health Canada-recognized indication for HBOT. No direct Canadian connection identified.
Study Limitations
As a case report, this study describes only one patient's experience, which limits its generalizability to a wider population.